Insider Transactions in Q4 2024 at Edgewise Therapeutics, Inc. (EWTX)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 11
2024
|
R Michael Carruthers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+47.65%
|
$0
$0.71 P/Share
|